期刊文献+

Thyroxine treatment for elderly patients with heart failure and sick euthyroid syndrome 被引量:2

Thyroxine treatment for elderly patients with heart failure and sick euthyroid syndrome
下载PDF
导出
摘要 Objectives To evaluate the effect of thyroid hormone therapy with low dose of thyroxin on cardiac function in elderly patients with heart failure and sick euthyroid syndrome. Methods Forty-seven patients (33 males and 14 females, mean age 85.9+4.6 years,ranging from 80 to 99 years) with chronic heart failure (NYHA Ⅱ-Ⅳ) and low triiodothyronine (T3) state were randomly allocated to the treatment group or control group. The treatment group patients received oral administration of levothyroxine sodium (Euthyrox) 25-50mg/d in addition to conventional therapy of heart failure, whereas patients in control group were given conventional therapy only. Serum level of total T3 (TT3), free T3 (FT3), total thyroxine (TT4), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) were determined. For both groups, left ventricular ejection fraction (LVEF) and stroke volume (SV) were assessed by two-dimensional echocardiography before and at 8 weeks after treatment. The changes of these parameters after the treatment were evaluated by adjusting heart rate in the two groups. Results The reduced serum T3 level in the treatment group was corrected after thyroid hormone therapy,and these patients had a significant improvement in cardiac function after treatment. By contrast, in the control group only changes of serum TT3 and TT4 levels and SV and LVEF after treatment were statistically significant. The heart rate-adjusted mean SV and LVEF in both groups were also increased, which was significantly greater in the treatment group than in the control group. Conclusion In the elderly patients with heart failure and sick euthyroid syndrome, addition of thyroxine at a low dosage to the conventional treatment could effectively improve the low T3 state and cardiac function independent of changes of heart rate. Objectives To evaluate the effect of thyroid hormone therapy with low dose of thyroxin on cardiac function in elderly patients with heart failure and sick euthyroid syndrome.Methods Forty-seven patients(33 males and 14 females,mean age 85.9±4.6 years, ranging from 80 to 99 years)with chronic heart failure(NYHAⅡ-Ⅳ)and low triiodothyronine(T_3)state were randomly allocated to the treatment group or control group.The treatment group patients received oral administration of levothyroxine sodium(Euthyrox)25-50 mg/d in addition to conventional therapy of heart failure,whereas patients in control group were given conventional therapy only.Serum level of total T_3(TT_3),free T_3(FT_3),total thyroxine(TT_4),free thyroxine(FT_4),and thyroid-stimulating hormone(TSH)were determined.For both groups,left ventricular ejection fraction(LVEF)and stroke volume(SV)were assessed by two-dimensional echocardiography before and at 8 weeks after treatment.The changes of these parameters after the treatment were evaluated by adjusting heart rate in the two groups.Results The reduced serum T_3 level in the treatment group was corrected after thyroid hormone therapy, and these patients had a significant improvement in cardiac function after treatment.By contrast,in the control group only changes of serum TT_3 and TT_4 levels and SV and LVEF after treatment were statistically significant.The heart rate-adjusted mean SV and LVEF in both groups were also increased,which was significantly greater in the treatment group than in the control group.Conclusion In the elderly patients with heart failure and sick euthyroid syndrome,addition of thyroxine at a low dosage to the conventional treatment could effectively improve the low T_3 state and cardiac function independent of changes of heart rate.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2006年第4期242-245,共4页 老年心脏病学杂志(英文版)
关键词 HEART FAILURE sick euthyroid SYNDROME ELDERLY THYROXINE heart failure sick euthyroid syndrome elderly thyroxine
  • 相关文献

参考文献22

  • 1[1]Slater A.Thyroid disease and heart.Prac Cardiol 1991;17:28.
  • 2[2]Zhu Y,Gong L,Zhuo Y,et al.Investigation of subclinical heart failure and its related factors in the aged.Zhonghua Lao Nian Yi Xue Za Zhi 2002;22:171-3.(in Chinese)
  • 3[3]Tang JH,Zhao SP.Abnormal alterations of thyroid hormone in congestive heart failure.Hunan Yi Xue 2000;17:22-3.(in Chinese)
  • 4[4]Kimura T,Kanda T,Kuwabara A,et al.Participation of the pituitary-thyroid axis in the cardiovascular system in elderly patients with congestive heart failure.J Med 1997;28:75-80.
  • 5[5]Chatterjee K.Primary diastolic heart failure.Am J Geriatr Cardiol 2002; 1:178-87.
  • 6[6]Creager MA,Fxon DP,Cutler SS,et al.Contribution of vasopression to vasoconstriction in patients with congestive heart failure:companion with to rennin-angiotensin system and the sympathetic nervous system.J Am Coll Cardiol 1986;12:758-62.
  • 7[7]Raine A,Erne P,Burgisser E,et al.Atrial natriuretic factor in congestive heart failure.Lancet 1986;1:106.
  • 8[8]Wang XD,Fu Y.Correlation of heart failure and euthyroid sick syndrome.Shi Jie Ji Wei Zhong Bing Yi Xue Za Zhi 2004;1:13-8.(in Chinese)
  • 9[9]Aronow WS,Ahn C,Kronzon I.Comparison of incidences of congestive heart failure in older African-Americans,Hispanics,and Whites.Am J Cardiol 1999;84:611-2.
  • 10[10]Kiss E,Jakab GK,ranias EG,et al.Thyroid hormone induced alterations in phospholamban protein expression.Regulatory effects on carcoplasmic reticulum Ca2+ transport and myocardial relaxation.Circ Res 1994;75:245-51.

同被引文献25

  • 1章秋芳,徐建平,王中英.小剂量甲状腺素治疗慢性心衰伴甲状腺功能正常的病态综合征疗效观察[J].心脑血管病防治,2006,6(6):405-406. 被引量:3
  • 2Shanoudy H, Soliman A, Moe S, et al. Early manifestations of "sick euthyroid" syndrome in patients with compensated chronic heart failure[J]. J Cardi Fail,2001,7(2) : 146 - 152.
  • 3Yazici M, Gorgulu S, Sertbas Y, et al. Effects of thyroxin therapy on car- diac function in patients with subclinical hypothyroidism: index of myocar- dial performance in the evaluation of left ventricular function[J]. Int J Cardiol,2004,95(2) : 135 - 143.
  • 4Danzi S, Klein I. Thyroid hormone and the cardiovascular system[J]. Med Clin North Am,2012,96(2) :257 - 68.
  • 5Yu Z, Wang T, Xu L, et al. Thyroid hormone increased L-type calcium channel mRNA expression and L-type calcium current of myocytes in rabbits [J]. Bio-Med Mater Eng,2012,22( 1 ) :49 - 55.
  • 6Iordanidou A, Hadzopoulou-Cladaras M, Lazou A. Non-genomic effects of thyroid hormone in adult cardiac myecytes: relevance to gene expression and cell growth[J]. Mol Cell Biochem,2010,340(1 -2):291 -300.
  • 7Tomanek R J. Cardiac Hypertrophy[M]//Coronary Vasculature. Springer US,2013:221 - 246.
  • 8Klein I. Thyroid hormone and blood pressure regulation[ J]. Cttrr Hyper- ten Rep, 2003,5 ( 6 ) : 513 - 520.
  • 9Trivieri MG, Oudit GY, Sah R, et al. Cardiac-specific elevations in thy- roid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction [ J ]. Pro Nat Acad Scien, 2006, 103 ( 15 ) : 6043 - 6048.
  • 10Kunaaan JA, Vogelsang KA, Thomas TA, et al. L-Thyroxine activates Akt signaling in the heart[J]. J Mol Cell Cardiol,2005,39(2):251 -258.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部